Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Telbivudine

A thymidine nucleoside analogue approved in the United States in 2006 for chronic hepatitis B: once activated by the cells, it blocks the virus's DNA polymerase. It was later withdrawn from the market. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It is the mirror image of natural thymidine, like a left hand compared with a right one: it has the L configuration instead of the D form found in our DNA.

TelbivudineGo to the active ingredient →
TelbivudineActive ingredientTelbivudineCat. No. P-T039-001CAS 3424-98-4
Telbivudine-d4Isotopically labelledTelbivudine-d4Cat. No. P-T039-002CAS 1134182-00-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.